OTC · CIK 0001865248
CMCAF Piermont Valley Acquisition Corp
Insider trading from SEC Form 4. Last filing Jul 15, 2025.
In brief
Piermont Valley Acquisition Corp (CMCAF) has 1 SEC Form 4 filing on file from 1 insider, the latest filed on Jul 15, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Piermont Valley Acquisition Corp, scored.
Transactions
Every row filed, 2 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 11, 2025 | Vikasati Partners LLC Chief Executive Officer | JOther Class A Ordinary Share | -2,238,999 | $0.00 | $0 | 1,686,001 | Jul 15, 2025 |
| Jul 11, 2025 | Vikasati Partners LLC Chief Executive Officer | JOther Class B Ordinary Sharesderivative | -1 | - | - | 0 | Jul 15, 2025 |
Questions about CMCAF
Answered from the filings on this page, as of the latest one.
Are insiders buying CMCAF?
No. In the last 90 days no insider at Piermont Valley Acquisition Corp bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade CMCAF on the open market?
No open-market trade has been scored at Piermont Valley Acquisition Corp. The latest Form 4 on file was filed on Jul 15, 2025 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Piermont Valley Acquisition Corp?
1 person has filed a Form 4 at Piermont Valley Acquisition Corp, among them Vikasati Partners LLC (Chief Executive Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.